News

Latest News

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

FLORENCE, Italy and NEW YORK, May 23, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and...
Fair Play Menarini International Award, here are the dates of the 2024 edition

Fair Play Menarini International Award, here are the dates of the 2024 edition

FLORENCE, May 14th 2024 – Preparations are in full swing for the upcoming Fair Play Menarini International Award, the event that, every year, celebrates athletes who have become...
VERONESE, A RIOT OF COLOURS The new Menarini Art Volume, dedicated to the great painter, showcased in Turin

VERONESE, A RIOT OF COLOURS The new Menarini Art Volume, dedicated to the great painter, showcased in Turin

Turin, 6 May 2024 - The latest volume of the Menarini Group’s prestigious art series, showcased on Sunday 5 May at Palazzo Madama in Turin, takes us back to the pomp of the...
4 in 10 elderly excluded on the basis of their age from getting the best health-care, globally. Carta of Florence, the first manifesto against health ageism, released

4 in 10 elderly excluded on the basis of their age from getting the best health-care, globally. Carta of Florence, the first manifesto against health ageism, released

FLORENCE, Italy - 9th April, 2024 - Fondazione Menarini, in the forefront of the fight against discrimination in health-care of the elderly, has contributed to the development of the...
Le Volpi Rosse Menarini conquistano il secondo posto all'Eurocup 3

Le Volpi Rosse Menarini conquistano il secondo posto all'Eurocup 3

Content available only in italian language

New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection

New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection

Malvern, PA, Parsippany, NJ, and Florence, Italy - February 20, 2024 – Venatorx Pharmaceuticals,  Melinta Therapeutics LLC (“Melinta”), and Menarini Group today...
Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Malvern, PA, and Florence, Italy, January 9th, 2024  – Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for...
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

FLORENCE, Italy and NEW YORK, January 4, 2024: The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline...
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC)

Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC)

FLORENCE, Italy and NEW YORK, December 11, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and...
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer

FLORENCE, Italy and NEW YORK, December 8, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and...
Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology

FLORENCE, Italy and NEW YORK, Nov. 20, 2023 -- The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline...
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

FLORENCE (Italy) and HONG KONG (China), November 7, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and SciClone...
European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

Brussels (Belgium) and Florence (Italy), 19 October 2023 – The European Organisation for Research and Treatment of Cancer (EORTC) and the Menarini Group (Menarini), a leading...
The 2023 Season gets underway for the  Volpi Rosse Menarini Wheelchair Basketball Team

The 2023 Season gets underway for the Volpi Rosse Menarini Wheelchair Basketball Team

The Volpi Rosse Menarini are once again setting their sights on the net, as the wheelchair basketball team takes to the court for the start of a new season in the Serie A FIPIC National...
European Commission Approves Menarini Group’s ORSERDU<sup>®</sup> (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

FLORENCE (Italy) and NEW YORK, NY, September 20, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline...
The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare

The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare

FLORENCE (Italy) and New York, NY, August 30, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline...
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer

FLORENCE (Italy) and NEW YORK, NY, July 21, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline...
Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole

Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole

FLORENCE, July 5, 2023 – This evening, the grand finale of the XXVII edition of the Menarini International Fair Play Awards was warmly greeted by over one thousand spectators at...
Fair Play Menarini International Awards,  excitement is building for the awards ceremony after the  “The Champions Tell their Stories”

Fair Play Menarini International Awards, excitement is building for the awards ceremony after the “The Champions Tell their Stories”

FLORENCE, July 4th, 2023 – The XXVII edition of the Fair Play Menarini International Awards is well under way.  The 2023 edition of the three-day event, centred around the...
Great news at the Fair Play Menarini International Awards,  tennis player Francesca Schiavone among the winners of the 2023 edition

Great news at the Fair Play Menarini International Awards, tennis player Francesca Schiavone among the winners of the 2023 edition

FLORENCE, July 3rd, 2023 – More surprises are in store in the XXVII edition of the Fair Play Menarini International Awards. Tennis legend, Francesca Schiavone, has joined the list...
1345678910Last

News Archive

 

Company Profile

Download Pdf

youtube Youtube

linkedin Linkedin

Blog Item Image
MENARINI EMPLOYEES
make all the difference, every day.

We are looking for talented people: in order to achieve our mission we need energetic, versatile people with initiative and team-work skills.
Every day we do our jobs with a great sense of commitment, knowing that we are adding more value to the creation of quality drugs.

READ MORE




menarini pills of art

Menarini Pills of Art

Today, with ‘Pills of Art’, Menarini enters the city’s museums to reveal some of the curious facts on the works of the most well-known Renaissance painters. An initiative which confirms the company’s affiliation with art, a close connection which has led them to publish, each year and for more than six decades, an art monograph

Read More
Fair Play Menarini

International Fair Play Menarini Award

International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in the world of sports for the brilliant results attained whilst fully respecting the rules

Read More
Menarini and Farmindustria

Menarini and Farmindustria: together we won’t rest

COVID -19 has brought many changes to our habits and our daily lives, but together we can face - and overcome - our fears. Menarini and Farmindustria, like all of us, won't rest.

Read More
EFPIA

EFPIA - We won’t rest campaign

MENARINI SUPPORTS THE EFPIA CAMPAIGN - WE WON'T REST: Disease never takes a break, so neither do we. We won't rest until people around the world see a brighter tomorrow.

Read More
newsletter

Subscribe to the newsletter

Subscribe to the newsletter to be updated on Menarini news.

Subscribe
Media Contact

Media Contact

To access the service it is necessary to declare to have read the privacy information.

Read More

The Menarini Blog

MENARINI BLOG

  • WeAreMenarini
  • News Menarini
I protagonisti delle Volpi Rosse Menarini: Lorenzo Bassoli e Mattia Scandolaro si raccontano
Read More
  • WeAreMenarini
Comprendere e aderire alla cultura aziendale di Menarini: il Buddy Program di Berlin-Chemie
Read More
  • WeAreMenarini
  • News Menarini
Dialogs Beyond Borders: conversazioni a tu per tu con i premi Nobel
Read More

Go to menarini for people

menarini for people

Discover our responsibility projects to stand close to people

read more